NewsKopran's Subsidiary Appoints Chandresh Gandhi as Independent Director, Announces Rights Issue to Raise Rs.18.75 CrKopran's Subsidiary Appoints Chandresh Gandhi as Independent Director, Announces Rights Issue to Raise Rs.18.75 Cr
Kopran Research Laboratories Limited (KRLL), a subsidiary of Kopran Limited, approved the appointment of Mr. Chandresh Gunvant Gandhi (DIN: 00707947) as Additional Independent Director for a five-year term from May 18, 2026 to May 17, 2031, subject to shareholder approval. The Board also approved a rights issue in the ratio of 1 share for every 12 held at a face value of 10/- and a premium of Rs.90/- per share, aiming to raise Rs.18.75 Cr for working capital requirements.
*this image is generated using AI for illustrative purposes only.
Kopran Research Laboratories Limited (KRLL), a subsidiary of Kopran Limited, convened a Board of Directors meeting on May 18, 2026, and approved two significant corporate actions — the appointment of an Additional Independent Director and a rights issue to meet working capital needs. The disclosure was made pursuant to Regulation 30(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Appointment of Additional Independent Director
The Board of KRLL, based on the recommendation of its Nomination and Remuneration Committee, approved the appointment of Mr. Chandresh Gunvant Gandhi as Additional Director in the Non-Executive, Independent Category. Mr. Gandhi, who also serves as an Independent Director of Kopran Limited, has been appointed for a first term of five consecutive years, subject to approval by the members of the company at the Annual General Meeting.
Key details of the appointment are summarised below:
| Parameter: | Details |
|---|---|
| Name: | Mr. Chandresh Gunvant Gandhi |
| DIN: | 00707947 |
| Designation: | Additional Director (Non-Executive, Independent Category) |
| Term: | First term of 5 consecutive years |
| Appointment Date: | May 18, 2026 |
| Tenure End Date: | May 17, 2031 |
| Subject To: | Approval of shareholders at Annual General Meeting |
| Relationship with Other Directors: | None |
| Debarment Status: | Not debarred from holding office of director by any SEBI order or any such authority |
Profile of Mr. Chandresh Gunvant Gandhi
Mr. Chandresh Gunvant Gandhi is a Chartered Accountant with more than 30 years of professional practice. He is the Managing Partner of M/s Dosi and Jain, a Chartered Accountant firm. His professional experience spans a broad range of audit, advisory, and taxation engagements, including:
- Concurrent Auditor of a leading foreign bank for more than two decades, covering All India Inward and Outward remittances — FTU unit and Imports/Exports Trade Unit as per Reserve Bank of India guidelines
- Internal Auditor for a leading commodity exchange in India for almost 10 years
- Statutory Auditor of a listed company for more than 20 years
- Conducted Statutory audit of nationalised bank branches allotted on the basis of empanelment
- Provided advisory services and representation before authorities in Auditing and Accounting, Local and International Taxation, including interpretation of Tax Treaties, Transfer Pricing, and FEMA issues relating to Inbound and Outbound Investments under RBI guidelines for NRIs, local corporates, and foreign companies
- Advised on cross-border transactions involving structuring from a taxation point of view under the Double Taxation Avoidance Agreement (DTAA) with various countries, and represented before tax authorities in assessments, appeals, and compounding matters with the RBI
Rights Issue to Fund Working Capital
In addition to the directorial appointment, the KRLL Board also approved the issuance of rights shares to raise funds for working capital requirements. The key terms of the rights issue are outlined below:
| Parameter: | Details |
|---|---|
| Issue Type: | Rights Issue |
| Ratio: | 1 share for every 12 held |
| Face Value: | 10/- |
| Premium: | Rs.90/- per share |
| Purpose: | Working capital requirement |
| Amount to be Raised: | 18.75 Cr |
The disclosure was signed by Sunil Sodhani, Company Secretary & Compliance Officer of Kopran Limited (Membership No. FCS 3897), and filed with both BSE Limited and the National Stock Exchange of India Limited in accordance with applicable regulatory requirements.
Historical Stock Returns for Kopran
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.43% | +3.32% | +6.84% | +26.88% | -15.07% | -14.68% |
How will the ₹18.75 crore raised through the rights issue be deployed, and what specific working capital gaps or expansion plans does KRLL aim to address in the near term?
Given that Mr. Chandresh Gandhi serves as Independent Director on both Kopran Limited and KRLL simultaneously, how might this dual role influence governance dynamics and potential conflicts of interest between the parent and subsidiary?
Could the rights issue at a 1:12 ratio signal further capital-raising rounds ahead, and how might existing minority shareholders respond to potential equity dilution?
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
